Phreesia Inc
Phreesia Inc (PHR) Covered Calls
As of September 18, 2026, PHR has 7 covered call opportunities in the coming three months. Return ranges from 22.1 to 48.3% until expiration. Annualized return ranges from 22.3 to 125.9%. The nearest expiration is November 20, 2026. Maximum potential profit is $497.
Read more
Running PHR covered calls helps you generate consistent income from Phreesia Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Phreesia Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best PHR covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if PHR stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling PHR covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Phreesia Inc covered call is worth writing.
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients.
In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and patient reported outcome (PRO) data for approximately 25 specialties, as well as enables healthcare services clients to communicate with their patients through surveys, announcements, text and email messaging, and health campaigns; and COVID-19 support modules for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is headquartered in Raleigh, North Carolina.
Income-focused investors, long-term PHR holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling PHR covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Phreesia Inc covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryHealth Information Services
- SectorHealthcare
- IV percentile20.24% Subdued
- Market cap (M$)623
- 52 weeks high-59.84%
- 52 weeks low29.21%
- Analyst recommendationBuy
1.95 - Target price$13.94
38.84% above the current stock price - Dividend—
- Payout ratio0.00%
- Earnings date2026-12-14
- P/E59.44
- Future P/E15.60
- EPS (ttm)0.17
- EPS growth next 5 years164.07%
As of September 18, 2026
| 2026-11-20 | 64 | 12.50 | 21.60 | 0.05 | 0.65 | 227.00 | 22.08 | 125.93 | -0.49 | +0.26 | 0 | 0.60 |
| 2026-12-18 | 92 | 12.50 | 21.60 | 0.20 | 0.80 | 242.00 | 23.54 | 93.40 | -1.95 | +0.31 | 47 | 0.60 |
| 2027-04-16 | 211 | 15.00 | 45.91 | 0.25 | 1.00 | 497.00 | 48.35 | 83.63 | -2.43 | +0.28 | 0 | 0.75 |
| 2027-01-15 | 120 | 12.50 | 21.60 | 0.30 | 1.05 | 252.00 | 24.51 | 74.56 | -2.92 | +0.35 | 260 | 0.75 |
| 2027-03-19 | 183 | 12.50 | 21.60 | 0.60 | 2.30 | 282.00 | 27.43 | 54.71 | -5.84 | +0.47 | 3 | 1.70 |
| 2027-04-16 | 211 | 12.50 | 21.60 | 0.75 | 1.65 | 297.00 | 28.89 | 49.98 | -7.30 | +0.44 | 0 | 0.90 |
| 2027-12-17 | 456 | 12.50 | 21.60 | 0.65 | 3.80 | 287.00 | 27.92 | 22.35 | -6.32 | +0.55 | 1 | 3.15 |
As of September 18, 2026
Sell covered calls with the data behind you
Find the best PHR covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→